The results showed that high expression of CLDN1 and HCAR3 was associated with poor prognosis, whereas high expression of FNBP1L and BRCA2 was associated with good prognosis in the TCGA ESCC cohort (Figure 2). The gene discussed is BRCA2; the disease is esophageal squamous cell carcinoma.